Editor's Choice
Invesco launches new equity fund
|Invesco said the new fund will give Australian investors access to a systematic global equity strategy with a 20-year track record.
FCA pursues Neil Woodford again
|The Financial Conduct Authority (FCA) is going after failed fund manager Neil Woodford again, this time for allegedly providing unauthorised investment advice via W4.0, his Dubai-based investment platform.
Former APRA deputy chair launches retirement solutions startup
|A former APRA deputy chair has launched CipherIQ, a new venture that provides retirement solutions via account-based pensions in partnership with superannuation funds, financial advisers and retirees.
Products
Featured Profile

Brian Redican
CHIEF ECONOMIST
NEW SOUTH WALES TREASURY CORPORATION
NEW SOUTH WALES TREASURY CORPORATION
What makes an economist an economist? TCorp chief economist Brian Redican reflects on over three decades of navigating Australia's economic cycles. Riddhima Talwani writes.







Comparing to the pharmaceutical industries: We do not observe doctors being directly employed by Pharmaceutical companies. Any semblance of independence in medical advice would otherwise be irreparably damaged.
Why doesn't anyone look at the doctor & pharmaceuticals relationship of kickbacks on prescribing medicines?
The pharmaceutical industry is more corrupt than any industry.
Leave the planners alone, get the Cowboys but leave the majority of us who do an honest job alone.